Holen Sie sich die Stockscreener-App
67.15
1.39%
0.92
Schlusskurs vom Vortag:
$66.23
Offen:
$66.33
24-Stunden-Volumen:
1.59M
Relative Volume:
1.32
Marktkapitalisierung:
$3.47B
Einnahmen:
$412.82M
Nettoeinkommen (Verlust:
$-8.19M
KGV:
-435.76
EPS:
-0.1541
Netto-Cashflow:
$64.17M
1W Leistung:
+5.45%
1M Leistung:
+35.38%
6M Leistung:
+266.74%
1J Leistung:
+352.49%
1-Tages-Spanne:
$65.88
$69.80
1-Wochen-Bereich:
$62.30
$69.80
52-Wochen-Spanne:
$13.95
$69.80
Caredx Inc Stock (CDNA) Company Profile
Firmenname
Caredx Inc
Sektor
Branche
Telefon
415-287-2300
Adresse
8000 MARINA BLVD, BRISBANE, CA
Compare CDNA vs TMO, DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDNA
Caredx Inc
|
67.15 | 3.29B | 412.82M | -8.19M | 64.17M | -0.1541 |
TMO
Thermo Fisher Scientific Inc
|
654.80 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
214.06 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
410.35 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.78 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
258.21 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Caredx Inc Stock (CDNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-06 | Herabstufung | Craig Hallum | Buy → Hold |
| 2025-08-26 | Eingeleitet | William Blair | Mkt Perform |
| 2025-01-15 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Underweight |
| 2024-08-19 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-05-13 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-05-01 | Hochstufung | Craig Hallum | Hold → Buy |
| 2023-11-09 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2023-08-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-05-11 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-03-07 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2023-03-03 | Herabstufung | Craig Hallum | Buy → Hold |
| 2023-03-03 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2022-04-25 | Eingeleitet | Stephens | Overweight |
| 2021-07-20 | Fortgesetzt | BTIG Research | Buy |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-02-26 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-10-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-08 | Bestätigt | H.C. Wainwright | Buy |
| 2020-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2020-08-05 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-26 | Eingeleitet | BTIG Research | Buy |
| 2020-06-19 | Bestätigt | H.C. Wainwright | Buy |
| 2019-10-01 | Fortgesetzt | Craig Hallum | Buy |
| 2019-05-09 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2019-02-15 | Eingeleitet | Jefferies | Buy |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-09-18 | Bestätigt | H.C. Wainwright | Neutral |
| 2017-11-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-06-14 | Bestätigt | Mizuho | Buy |
| 2015-09-29 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-25 | Eingeleitet | Craig Hallum | Buy |
| 2015-03-18 | Bestätigt | Mizuho | Buy |
Alle ansehen
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CareDx, Inc (CDNA) stock price, news, quote and history - uk.finance.yahoo.com
Caredx Inc stock hits 52-week high at 65.53 USD - Investing.com
Consumer Confidence Falls Amid Ongoing Geopolitical Tensions: 4 Picks - TradingView
CareDx, Inc. (CDNA) Stock Price, News, Quote & History - Yahoo! Finance Canada
CareDx Refocused On Transplant Testing, And Wall Street Noticed - Finimize
CareDx, Inc. (CDNA) stock price, news, quote and history - Yahoo Finance Singapore
How (CDNA) Movements Inform Risk Allocation Models - Stock Traders Daily
CareDx: I Was Wrong, But The Rally Has Outrun The Fundamentals (Rating Upgrade) - Seeking Alpha
Biotech Stocks At 52-Week HighsCDNA +13%, GRAL +15%, TWST +16%, ADPT, RVTY - RTTNews
CareDx (CDNA) Stock Jumps 13.0%: Will It Continue to Soar? - Yahoo Finance
CareDx Inc (CDNA) Stock Up 13.0% but GF Value Says Overvalued -- GF Score: 66/100 - GuruFocus
CareDx +14% on Fresh $74 Analyst Price Target - TIKR.com
BTIG raises CareDx stock price target to $74 on transplant outlook - Investing.com
CDNA Maintained by BTIG -- Price Target Raised to $74.00 - GuruFocus
BTIG raises CareDx stock price target to $74 on transplant outlook By Investing.com - Investing.com South Africa
CareDx Is Maintained at Buy by BTIG - Moomoo
Zacks.com featured highlights include CareDx, Ciena, Celestica, Materion and MACOM Technology Solutions - Yahoo Finance
Medicare Lab Fee Changes Impact BillionToOne, CareDx Differently - Benzinga
A Look at CareDx Inc (CDNA) After 4.0% Gain -- GF Value $25.41 v - GuruFocus
Caredx Inc stock hits 52-week high at 55.21 USD By Investing.com - Investing.com India
Caredx Inc stock hits 52-week high at 55.21 USD - Investing.com
CDNA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of July 22, 2022 in the Class Action Filed on Behalf of CareDx, Inc. Limited Shareholders - TMX Newsfile
Naveris: 2025 revenue $34,337,000 (CareDx 8-K/A) - app.dealroom.co
CAREDX INC (NASDAQ:CDNA): High Growth and Improving Fundamentals Fuel Bullish Case - ChartMill
CareDx, Inc. (CDNA) Investor Outlook: Riding High with a 52.20% Revenue Growth in the Healthcare Sector - DirectorsTalk Interviews
CareDx (CDNA) CFO uses 8,220 shares to cover RSU taxes - Stock Titan
CareDx (NASDAQ: CDNA) CCO has 6,688 shares withheld for taxes - Stock Titan
Caredx Inc stock hits 52-week high at 53.71 USD By Investing.com - Investing.com Nigeria
Caredx Inc stock hits 52-week high at 53.71 USD - Investing.com
CareDx (NASDAQ:CDNA) Meets Minervini Trend Template with High-Growth Momentum - ChartMill
Oil Surge Continues on Escalating Middle East Crisis: 4 Defensive Picks - TradingView
CareDx (CDNA) Q2 2026 Earnings: EPS of $0.37 Beats Estimates by 55.79%Earnings Call Q&A - careplusvn.com
Are Medical Stocks Lagging CareDx (CDNA) This Year? - Yahoo Finance
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
CareDx (NASDAQ:CDNA) Screens Well on High Growth Momentum and Breakout Setup - ChartMill
CareDx (CDNA) Pulls Back to $48.92 as Transplant Diagnostics Stock Holds Range Between Support and ResistanceStop Loss Guidance - careplusvn.com
CDNA Initiates Coverage by Canaccord Genuity -- Price Target Set at $65 - GuruFocus
Canaccord Genuity Initiates Coverage of CareDx, BillionToOne With Buy Ratings - GenomeWeb
Canaccord initiates CareDx stock coverage with buy rating on testing By Investing.com - Investing.com South Africa
Canaccord Genuity Initiates CareDx at Buy With $65 Price Target - marketscreener.com
Canaccord initiates CareDx stock coverage with buy rating on testing - Investing.com India
CareDx (CDNA) Holds Steady at $50.11; Resistance at $52.62 in FocusOutside Reversal - careplusvn.com
CareDx (CDNA) is a Great Momentum Stock: Should You Buy? - Eastern Progress
Caredx Inc stock hits 52-week high at 49.77 USD By Investing.com - Investing.com Canada
Caredx Inc stock hits 52-week high at 49.77 USD - Investing.com
Is CareDx’s AI and EHR Push Reshaping Its Role In Transplant Care Infrastructure (CDNA)? - Sahm
Zacks Industry Outlook CareDx, BrightSpring and PACS - Yahoo Finance
CareDx (CDNA) Shares Jumped, So What Is Driving Attention Now? - Yahoo Finance
Is CareDx (CDNA) Fully Priced After Its Strong Three Year Run? - Yahoo Finance
Is CareDx Inc (CDNA) Overvalued After 3.5% Rally? GF Value Says - GuruFocus
CareDx Inc (1K9) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Finanzdaten der Caredx Inc-Aktie (CDNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.97%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):